They lower blood pressure (typically by 36 mm Hg systolic) through multiple mechanisms that extend beyond weight reduction
Additionally, semaglutide should not be used concurrently with other GLP-1 receptor agonists
The small study by researchers from the University at Buffalo set out to see if semaglutide could be used to replace mealtime insulin, to help reduce blood sugar levels and hypoglycaemia and improve glycaemic control
Which is what she offers in this information packed book
*Compounded versions of semaglutide are not FDA-approved, and neither the FDA nor any global regulatory agency has reviewed these products for safety, quality, or efficacy
We saw a need for a user-friendly and supportive space where medically supervised care is accessible, personalized, and designed for sustainable results